Piperidine derivatives

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/12 (2006.01) A61K 31/435 (2006.01) C07D 211/18 (2006.01) C07D 211/22 (2006.01) C07D 417/12 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2060965

ABSTRACT OF THE DISCLOSURE Disclosed are compounds of formula (I) Image (I) in which A represents a group selected from the following formulas (a) to (f) Image (a) Image (b) Image (c) Image (d) Image (e) or Image (f) wherein R1 and R2 may be the same or different and each represents a hydrogen atom, a C1-C6 alkyl group, a phenyl group or an aryl(C1-C4)alkyl group, R3 represents a C1-C6 alkyl group, R4 represents a hydrogen atom, a C1-C6 alkyl group, a phenyl group or an aryl(C1-C4)alkyl group, R5, R6 and R7 may be the same or different and each represents a hydrogen atom, an amino group, a halogen atom, a C1-C4 alkoxy group or a phthalimide group and X represents O or NH, physiologically acceptable salts and quaternary ammonium salts thereof. The compounds are selective antagonists of 5HT at 5-HT3 receptors and useful in the treatment of psychotic disorders, neurotic diseases, gastric stasis symptoms, gastrointestinal disorders, nausea and vomiting.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1558008

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.